- Panic attacks recur because each one sensitises the amygdala; the root is GABA-A deficit, not willpower.
- Ashwagandha works on cortisol (wrong system); L-theanine is indirect and short-acting; glycine eases symptoms but not the cause.
- Vitexin is studied for binding GABA-A directly (like benzodiazepines) as a modulator, without dependence.
- Vitexin + Hericium erinaceus pair the receptor side with NGF neuroregeneration; others can complement, especially for sleep.
Why do panic attacks recur?
Many people suffer from exhausting panic attacks, especially at night. Online shops offer dozens of supplements — ashwagandha, L-theanine capsules, glycine. Do any of them really help against panic attacks? Each panic attack leaves a trace — not metaphorical, but physiological. The amygdala, responsible for threat recognition, becomes more sensitive after each attack. The threshold at which it fires drops lower. This is why willpower and conscious-thinking exercises often fail or work only briefly: they help control the symptom but do not remove the neurochemical imbalance behind the attacks.
GABA deficiency — the real cause of panic attacks
GABA (gamma-aminobutyric acid) is the main inhibitory neurotransmitter in the brain. Its function is to halt overly active neuron excitation. When GABA-system activity decreases or GABA-A receptors lose sensitivity, the brain becomes prone to excessive activation. This is why benzodiazepines (such as diazepam) act so quickly: they bind directly to GABA-A receptors and amplify their activity. The problem is that over time the receptors adapt, doses must increase, and dependence develops. What weakens the GABA system? Magnesium deficiency, chronic sleep loss, alcohol and caffeine all weaken the GABAergic system.
Ashwagandha for panic attacks — why it is not enough
Ashwagandha is an adaptogen — which is both its strength and its weakness. It works through the HPA axis (hypothalamus–pituitary–adrenal), lowering cortisol and helping the body tolerate chronic stress. But there are two problems. First, adaptation: the body adjusts to it, so the effect naturally weakens with longer use. Second, it works on the wrong system: panic attacks arise from GABA-A deficit and amygdala hypersensitivity, not from cortisol levels. Ashwagandha is genuinely excellent for chronic stress and elevated cortisol — but not for the direct panic mechanism.
L-theanine for panic attacks — why it is not enough
L-theanine is one of the most popular natural calming agents, and its popularity is justified. It acts as a glutamate-receptor modulator — competing with glutamate (the excitatory neurotransmitter) and indirectly increasing GABA activity. But the indirect effect has limits: research suggests L-theanine effectively helps people with mild anxiety, not panic disorder. It is also rapidly metabolised (short half-life), so it does not provide the long-term GABA support needed. Where L-theanine truly excels: falling asleep — a GABA and L-theanine combination significantly improves sleep onset and NREM sleep quality.
Glycine for panic attacks — a symptom suppressor, not a cause solution
Glycine acts differently from GABA — it activates its own receptors in the spinal cord and brainstem, reducing muscle tension and physiological arousal, and lowers body temperature at night to aid sleep. An important advantage: glycine can dampen the effect of adrenaline through the sympathetic nervous system — meaning the physical symptoms of an attack already underway (racing heart, trembling, heat) may ease. The drawback: glycine does not provide long-term GABA support, does not stimulate nerve growth factor (NGF), and does not restore the amygdala's sensitivity threshold. It helps during an attack but does not reduce the likelihood of future ones.
Vitexin — a direct GABA-A receptor agonist
Vitexin (a flavone glycoside from passionflower) does what neither ashwagandha nor L-theanine does: it is studied for binding directly to GABA-A receptors — the same receptor benzodiazepines bind to — but as a modulator, without the dependence and sedation. The important nuance: not every "vitexin" product on the market is equal. A capsule of dried passionflower powder and a concentrated extract with a standardised vitexin content are very different things.
Synergy: why vitexin and H. erinaceus work better together
Hericium erinaceus (Lion's Mane) is studied for restoring the nervous system through nerve growth factor (NGF), addressing the structural side, while vitexin addresses the receptor side. Together they target both the immediate (GABA-A) and the long-term (neuroregeneration) aspects. L-theanine, ashwagandha and glycine can be used alongside vitexin — their mechanisms do not clash and in some cases (especially for sleep) complement each other. Always discuss supplements with a healthcare professional, particularly if you take medication.
Vitexin is studied for binding GABA-A directly as a modulator, paired with Hericium erinaceus for NGF - addressing both the immediate and long-term sides of panic.
Vitexin 90 by Zenius Labs™ →Yes — their mechanisms do not clash. Ashwagandha helps manage cortisol in chronic stress, L-theanine improves sleep quality, and glycine dampens attack symptoms. Vitexin 90 by Zenius Labs™ acts as the base, the others as complementary support. Discuss combinations with a professional.
The minimum recommended course is 3 months. The H. erinaceus NGF effect accumulates gradually — stopping too early means the structural effect does not have time to establish. This is informational, not medical advice.
No. Vitexin is studied for modulating GABA-A receptors rather than suppressing the central nervous system — so it is examined for supporting calm without the sedation or dependence of benzodiazepines.
Each attack physiologically sensitises the amygdala, lowering the threshold at which it fires. Willpower exercises control the symptom but do not remove the underlying GABA-A deficit and amygdala hypersensitivity — which is why addressing the neurochemical side matters.
- Zhang W, et al. Medicinal herbs for the treatment of anxiety: systematic review and network meta-analysis. Phytomedicine. 2022. PubMed
- Kim S, et al. GABA and l-theanine mixture decreases sleep latency and improves NREM sleep. J Funct Foods. 2019. PubMed
- Bannai M, et al. The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. Neuropsychopharmacology. 2012. PubMed
- Farooqi AA, et al. Flavones bound in benzodiazepine site on GABA(A) receptor: anxiolytic-like and cognitive sparing effects. J Ethnopharmacol. 2018. PubMed
- Nagano M, et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res. 2010. PubMed
- Velasquez ACA et al. Effects of Passiflora incarnata and Valeriana officinalis in the control of anxiety due to tooth extraction: a randomized controlled clinical trial. Oral and maxillofacial surgery. 2024. PubMed
- Miyasaka LS et al. Passiflora for anxiety disorder. The Cochrane database of systematic reviews. 2007. PubMed
- Wolfman C et al. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacology, biochemistry, and behavior. 1994. PubMed
- Grundmann O et al. Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system. Planta medica. 2008. PubMed
- Zhong H et al. Neonatal inflammation via persistent TGF-β1 downregulation decreases GABA(A)R expression in basolateral amygdala leading to the imbalance of the local excitation-inhibition circuits and anxiety-like phenotype in adult mice. Neurobiology of disease. 2022. PubMed
- Mori K et al. Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biological & pharmaceutical bulletin. 2008. PubMed
- Lai PL et al. Neurotrophic properties of the Lion’s mane medicinal mushroom, Hericium erinaceus (Higher Basidiomycetes) from Malaysia. International journal of medicinal mushrooms. 2013. PubMed
- Chiu CH et al. Erinacine A-Enriched Hericium erinaceus Mycelium Produces Antidepressant-Like Effects through Modulating BDNF/PI3K/Akt/GSK-3β Signaling in Mice. International journal of molecular sciences. 2018. PubMed
- Cipriano GL et al. Beyond Neurotrophins: A Proposed Neurotrophic-Epigenetic Axis Mediated by Non-Coding RNA Networks for Hericium erinaceus Bioactives-A Hypothesis-Driven Review. International journal of molecular sciences. 2026. PubMed
- Nagano M et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical research (Tokyo, Japan). 2010. PubMed
- Vigna L et al. Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers?. Evidence-based complementary and alternative medicine : eCAM. 2019. PubMed
- Koszła O et al. Biotransformation of Ganoderma lucidum and Hericium erinaceus for ex vivo gut-brain axis modulation and mood-related outcomes in humans: CREB/BDNF signaling and microbiota-driven synergies. Journal of ethnopharmacology. 2025. PubMed
- Pétursson H The benzodiazepine withdrawal syndrome. Addiction (Abingdon, England). 1994. PubMed
- Soyka M Treatment of Benzodiazepine Dependence. The New England journal of medicine. 2017. PubMed
- O’brien CP Benzodiazepine use, abuse, and dependence. The Journal of clinical psychiatry. 2005. PubMed
- Jeanclos E et al. Improved cognition, mild anxiety-like behavior and decreased motor performance in pyridoxal phosphatase-deficient mice. Biochimica et biophysica acta. Molecular basis of disease. 2019. PubMed
- Ratto D et al. Hericium erinaceus Improves Recognition Memory and Induces Hippocampal and Cerebellar Neurogenesis in Frail Mice during Aging. Nutrients. 2019. PubMed
- Amigó J et al. The absence of 5-HT(4) receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT(1A) autoreceptor. Neuropharmacology. 2016. PubMed
- Paliokha R et al. Effects of pre-gestational exposure to the stressors and perinatal mirtazapine administration on the excitability of hippocampal glutamate and brainstem monoaminergic neurons, hippocampal neuroplasticity, and anxiety-like behavior in rats. Molecular psychiatry. 2026. PubMed
- Cryan JF et al. The Microbiota-Gut-Brain Axis. Physiological reviews. 2019. PubMed
- Rutsch A et al. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology. Frontiers in immunology. 2020. PubMed
- Foster JA et al. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiology of stress. 2017. PubMed
- Bear T et al. The Microbiome-Gut-Brain Axis and Resilience to Developing Anxiety or Depression under Stress. Microorganisms. 2021. PubMed